Allergan Inc. Newsletter
-
Allergan Aesthetics Continues Its Mission of Empowering Women Through the Faces of Natrelle® Testimonial Program
04 Feb 2026 00:58 GMT
… Nicole Mowad-Nassar, President, Global Allergan Aesthetics and Senior Vice President … Program Terms and Conditions apply. Allergan Aesthetics, an AbbVie company, … breast implant surgery. About Allergan Aesthetics
At Allergan Aesthetics, an AbbVie company …
-
Allergan Sued Over 'Preservative Free' Eyedrop Labeling
30 Jan 2026 22:20 GMT
… PM EST) -- AbbVie unit Allergan USA was hit with a …
-
AbbVie Submits Regulatory Applications to FDA and EMA for Upadacitinib in Adults and Adolescents With Vitiligo
04 Feb 2026 00:59 GMT
… products and services in our Allergan Aesthetics portfolio. For more information …
-
New ANDA Cases - Fourth Quarter 2025
03 Feb 2026 23:53 GMT
… ,918,578
11,260,053
Allergan, Inc. v. Alembic Pharms. Ltd …
-
Bio-Stimulation Therapies Market Valuation, ROI Potential & Long-Term Growth Prospects 2026–2036
03 Feb 2026 11:48 GMT
… ., Merz Aesthetics, Inc., AbbVie Inc. (Allergan Aesthetics), Sinclair Pharma plc, Suneva … its entire range in 2023.
Allergan Aesthetics' expansion of SKINVIVE …
-
My Secret to a Youthful Neck at 57 Is This Firming Cream That’s Like a Mini-Facelift in a Bottle
03 Feb 2026 09:38 GMT
… considering SkinMedica is owned by Allergan, the makers of Botox, and …
-
The Science Behind the Syringe
03 Feb 2026 05:49 GMT
… skincare research and development at Allergan Aesthetics. “In partnership with … continued collaboration with AbbVie and Allergan Aesthetics,” Amin said. “This … technically challenging, industry driven problems.”
Allergan Aesthetics provided the cross linked …
-
Colorescience Is Acquired by Roundtable Healthcare Partners
03 Feb 2026 04:30 GMT
… brand was spun off from Allergan in 2012. It received a …
-
[Webcast Transcript] eDiscovery Lessons for 2026: Spotlighting the Top ESI Cases and Trends from 2025
02 Feb 2026 21:48 GMT
… ? And we see in the Allergan versus Revance case that the … its employee phones.
Essentially, that Allergan was going to have to … makes things more difficult for Allergan, and at some level, it … the one hand, there’s Allergan versus Revance, but on the …
-
Shanghai Henlius Biotech Announces FDA Acceptance of aBLA for Proposed Avastin® Biosimilar HLX04
02 Feb 2026 21:46 GMT
… date, beginning with Amgen / Allergan’s Mvasi® (bevacizumab-awwb), FDA …